NYSE:CRY - New York Stock Exchange, Inc. - Common Stock
Overall CRY gets a fundamental rating of 2 out of 10. We evaluated CRY against 187 industry peers in the Health Care Equipment & Supplies industry. CRY may be in some trouble as it scores bad on both profitability and health. CRY is valued quite expensively, but it does show have an excellent growth rating.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -0.16% | ||
ROE | N/A | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 4.83% | ||
PM (TTM) | -0.37% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1 | ||
Debt/FCF | N/A | ||
Altman-Z | 1.67 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.21 | ||
Quick Ratio | 2.93 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 59.6 | ||
Fwd PE | 265.53 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 23.14 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0% |
17.88
+0.25 (+1.42%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 59.6 | ||
Fwd PE | 265.53 | ||
P/S | 1.96 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 2.26 | ||
P/tB | N/A | ||
EV/EBITDA | 23.14 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -0.16% | ||
ROE | N/A | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | 4.83% | ||
PM (TTM) | -0.37% | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 4.21 | ||
Quick Ratio | 2.93 | ||
Altman-Z | 1.67 |